Bolutol en es it fr

Bolutol Brand names, Bolutol Analogs

Bolutol Brand Names Mixture

  • No information avaliable

Bolutol Chemical_Formula


Bolutol RX_link

Bolutol fda sheet

Bolutol FDA

Bolutol msds (material safety sheet)

Bolutol Synthesis Reference

P. L. CREGER, U.S. Pat. 3,674,836 (1972)

Bolutol Molecular Weight

250.333 g/mol

Bolutol Melting Point

61-63 oC

Bolutol H2O Solubility

10 mg/mL (in base)

Bolutol State


Bolutol LogP


Bolutol Dosage Forms

Tablets; Capsules

Bolutol Indication

For treatment of adult patients with very high elevations of serum triglyceride levels (types IV and V hyperlipidemia) who are at risk of developing pancreatitis (inflammation of the pancreas) and who do not respond adequately to a strict diet.

Bolutol Pharmacology

Gemfibrozil, a fibric acid antilipemic agent similar to clofibrate, is used to treat hyperlipoproteinemia and as a second-line therapy for type IIb hypercholesterolemia. It acts to reduce triglyceride levels, reduce VLDL levels, reduce LDL levels (moderately), and increase HDL levels (moderately).

Bolutol Absorption

Well absorbed from gastrointestinal tract (within 1-2 hours).

Bolutol side effects and Toxicity

Oral, mouse: LD50 = 3162 mg/kg. Symptoms of overdose include abdominal cramps, diarrhea, joint and muscle pain, nausea, and vomiting.

Bolutol Patient Information

Gemfibrozil is used to lower high triglyceride and cholesterol levels. Notify your physician if you are pregnant or nursing. Gemfibrozil should be taken 30 minutes before the morning and evening meals. This medication may cause dizziness or blurred vision; use caution while driving or operating hazardous machinery. Gemfibrozil may cause an increase in blood sugar. If you have diabetes mellitus, carefully monitor blood sugar levels. Notify your physician if you develop severe stomach pain, muscle pain or weakness, or unexplained fever.

Bolutol Organisms Affected

Humans and other mammals